IL146566A0 - A pharmaceutical composition containing anti-fas antibody - Google Patents
A pharmaceutical composition containing anti-fas antibodyInfo
- Publication number
- IL146566A0 IL146566A0 IL14656600A IL14656600A IL146566A0 IL 146566 A0 IL146566 A0 IL 146566A0 IL 14656600 A IL14656600 A IL 14656600A IL 14656600 A IL14656600 A IL 14656600A IL 146566 A0 IL146566 A0 IL 146566A0
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical composition
- composition containing
- containing anti
- fas antibody
- fas
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
- C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
- C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14303399 | 1999-05-24 | ||
PCT/JP2000/003324 WO2000071160A1 (fr) | 1999-05-24 | 2000-05-24 | Compositions medicinales contenant un anticorps anti-fas |
Publications (1)
Publication Number | Publication Date |
---|---|
IL146566A0 true IL146566A0 (en) | 2002-07-25 |
Family
ID=15329357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14656600A IL146566A0 (en) | 1999-05-24 | 2000-05-24 | A pharmaceutical composition containing anti-fas antibody |
Country Status (19)
Country | Link |
---|---|
US (1) | US6746673B2 (tr) |
EP (1) | EP1180369A4 (tr) |
KR (1) | KR20020008197A (tr) |
CN (1) | CN1191861C (tr) |
AU (1) | AU761544C (tr) |
BR (1) | BR0010909A (tr) |
CA (1) | CA2373992A1 (tr) |
CZ (1) | CZ20014181A3 (tr) |
HK (1) | HK1042049A1 (tr) |
HU (1) | HUP0201333A3 (tr) |
IL (1) | IL146566A0 (tr) |
MX (1) | MXPA01012206A (tr) |
NO (1) | NO20015711L (tr) |
NZ (1) | NZ515598A (tr) |
PL (1) | PL352159A1 (tr) |
RU (1) | RU2222347C2 (tr) |
TR (1) | TR200103396T2 (tr) |
WO (1) | WO2000071160A1 (tr) |
ZA (1) | ZA200109575B (tr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4772299A (en) | 1998-06-18 | 2000-01-05 | Karolinska Innovations Ab | Fas peptides and antibodies for modulating apoptosis |
HU228957B1 (en) * | 2001-07-02 | 2013-07-29 | Aimsco Ltd | Use anti-hla-antibody for production of pharmaceutical compotisions for the treatment of diseases involving prolierative immune response |
GB0201896D0 (en) * | 2002-01-28 | 2002-03-13 | Ice Biolog Ltd | Treatment |
PE20030340A1 (es) * | 2001-08-28 | 2003-04-05 | Sankyo Co | Metodo para el tratamiento o prevencion de desgaste oseo |
MXPA04007311A (es) * | 2002-01-28 | 2005-05-16 | Aimsco Ltd | Tratamiento de ms con suero de cabra. |
US6989386B2 (en) * | 2002-04-30 | 2006-01-24 | Dana-Farber Cancer Institute | Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same |
AU2003242265A1 (en) * | 2002-06-07 | 2003-12-22 | Sankyo Company, Limited | Combined effects of therapeutic or preventive agent composition for bone breakage |
US20050032807A1 (en) * | 2003-08-06 | 2005-02-10 | Rosenwald Lindsay A. | Methods of treating inflammatory diseases with ammonium salts of ornitihine derivatives |
GB0427568D0 (en) * | 2004-12-16 | 2005-01-19 | Resolution Chemicals Ltd | Particle-size reduction apparatus, and the use thereof |
US8052971B2 (en) * | 2005-11-21 | 2011-11-08 | MG Biologics | Oral use of specific antibodies for intestinal health |
CN101092417B (zh) * | 2006-06-19 | 2011-04-27 | 上海金色医药科技发展有限公司 | 一种叶酸类似物及用于医疗的叶酸类似物的盐 |
CN101820879B (zh) * | 2007-10-08 | 2013-01-02 | 疟疾药物投资公司 | 具有柔性侧链的抗疟用化合物 |
EP2310412B1 (en) | 2008-06-20 | 2018-02-21 | Novartis AG | Immunoglobulins with reduced aggregation |
BRPI0915414A2 (pt) | 2008-06-20 | 2021-09-08 | Novartis Ag | Métodos para identificar uma região propensa à agregação e uma região de ligação de macromolécula em uma proteína, bem como métodos para produzir uma variante de proteína e uma composição farmacêutica. |
WO2010013498A1 (ja) * | 2008-08-01 | 2010-02-04 | 学校法人聖マリアンナ医科大学 | 変形性関節症治療剤又は予防剤 |
KR20180056805A (ko) * | 2009-06-04 | 2018-05-29 | 노파르티스 아게 | IgG 콘쥬게이션을 위한 자리의 확인 방법 |
EP2266984A1 (en) * | 2009-06-26 | 2010-12-29 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Pyrido[2,3-d]pyrimidines as Wnt antagonists for treatment of cancer and arthritis |
KR101138460B1 (ko) | 2009-10-12 | 2012-04-26 | 한국생명공학연구원 | 항-fasn 자가면역 항체를 포함하는 간암 진단 마커 및 이의 항원을 포함하는 간암 진단용 조성물 |
WO2011046309A2 (en) * | 2009-10-12 | 2011-04-21 | Korea Research Institute Of Bioscience And Biotechnology | A diagnostic marker for hepatocellular carcinoma comprising anti-fasn autoantibodies and a diagnostic composition for hepatocellular carcinoma comprising antigens thereof |
WO2014022817A2 (en) | 2012-08-03 | 2014-02-06 | Novartis Ag | Methods to identify amino acid residues involved in macromolecular binding and uses therefor |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0021292B1 (en) * | 1979-06-14 | 1983-03-09 | The Wellcome Foundation Limited | Alkoxybenzylpyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof |
ZA861235B (en) * | 1985-03-08 | 1986-10-29 | Univ Princeton | Pyrido(2,3-d)pyrimidine derivatives |
DE3603577A1 (de) * | 1986-02-06 | 1987-08-13 | Joachim K Prof Dr Seydel | Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit |
NO169490C (no) * | 1988-03-24 | 1992-07-01 | Takeda Chemical Industries Ltd | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater |
JPH02237935A (ja) | 1989-03-10 | 1990-09-20 | Bio Kagaku Kenkyusho:Kk | エイズ処置剤 |
US5008391A (en) * | 1989-07-07 | 1991-04-16 | Eli Lilly And Company | Enantioselective synthesis of antifolates |
US4996207A (en) * | 1990-01-18 | 1991-02-26 | Nair Madhavan G | Three new non-polyglutamatable deazaaminopterins |
WO1991010448A1 (en) | 1990-01-19 | 1991-07-25 | German Cancer Research Center | A cell surface antigen associated with cellular apoptosis |
CA2071205C (en) | 1990-01-19 | 2000-03-14 | Peter H. Krammer | Cell surface antigen associated with cellular apoptosis |
CA2095518A1 (en) * | 1990-11-14 | 1992-05-15 | Jeffrey M. Blaney | Specific inhibition of dihydrofolate reductase and compounds therefor |
AU3276793A (en) * | 1991-12-20 | 1993-07-28 | Agouron Pharmaceuticals, Inc. | Antifolate quinazolines |
US5877176A (en) * | 1991-12-26 | 1999-03-02 | Cornell Research Foundation, Inc. | Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
US5426110A (en) * | 1993-10-06 | 1995-06-20 | Eli Lilly And Company | Pyrimidinyl-glutamic acid derivatives |
CA2158822C (en) * | 1994-09-27 | 2008-12-23 | Kusuki Nishioka | Therapeutic agent for rheumatic disease |
CA2210500A1 (en) * | 1995-01-16 | 1996-07-25 | Commonwealth Scientific And Industrial Research Organisation | Therapeutic compound - fatty acid conjugates |
US6221615B1 (en) * | 1995-05-12 | 2001-04-24 | Apoptosis Technology, Inc. | Peptides and compositions which modulate apoptosis |
CA2230852A1 (en) * | 1995-08-30 | 1997-03-06 | The Regents Of The University Of California | Therapy for cellular accumulation in chronic inflammatory diseases |
EP0897724A4 (en) * | 1996-03-19 | 2003-05-07 | Chugai Pharmaceutical Co Ltd | MEDICINE AGAINST UVEITY |
US6544523B1 (en) * | 1996-11-13 | 2003-04-08 | Chiron Corporation | Mutant forms of Fas ligand and uses thereof |
US6001962A (en) * | 1996-11-15 | 1999-12-14 | The Regents Of The University Of California | Modified Fas ligands |
IL123756A0 (en) * | 1997-03-21 | 1998-10-30 | Sankyo Co | Humanized anti-human FAS antibody |
IL123888A0 (en) * | 1997-04-01 | 1998-10-30 | Sankyo Co | Anti-fas antibodies |
US6098631A (en) * | 1998-01-21 | 2000-08-08 | The Regents Of The University Of Michigan | Compositions and methods for treating autoimmune disease |
-
2000
- 2000-05-24 NZ NZ515598A patent/NZ515598A/en unknown
- 2000-05-24 PL PL00352159A patent/PL352159A1/xx not_active Application Discontinuation
- 2000-05-24 CA CA002373992A patent/CA2373992A1/en not_active Abandoned
- 2000-05-24 TR TR2001/03396T patent/TR200103396T2/tr unknown
- 2000-05-24 AU AU49486/00A patent/AU761544C/en not_active Ceased
- 2000-05-24 BR BR0010909-6A patent/BR0010909A/pt not_active IP Right Cessation
- 2000-05-24 KR KR1020017015062A patent/KR20020008197A/ko not_active Application Discontinuation
- 2000-05-24 WO PCT/JP2000/003324 patent/WO2000071160A1/ja not_active Application Discontinuation
- 2000-05-24 CN CNB008107807A patent/CN1191861C/zh not_active Expired - Fee Related
- 2000-05-24 HU HU0201333A patent/HUP0201333A3/hu unknown
- 2000-05-24 RU RU2001131725/15A patent/RU2222347C2/ru not_active IP Right Cessation
- 2000-05-24 MX MXPA01012206A patent/MXPA01012206A/es unknown
- 2000-05-24 EP EP00931546A patent/EP1180369A4/en not_active Withdrawn
- 2000-05-24 CZ CZ20014181A patent/CZ20014181A3/cs unknown
- 2000-05-24 IL IL14656600A patent/IL146566A0/xx unknown
-
2001
- 2001-11-20 US US09/989,620 patent/US6746673B2/en not_active Expired - Fee Related
- 2001-11-20 ZA ZA200109575A patent/ZA200109575B/xx unknown
- 2001-11-23 NO NO20015711A patent/NO20015711L/no not_active Application Discontinuation
-
2002
- 2002-05-23 HK HK02103876.1A patent/HK1042049A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200109575B (en) | 2003-04-30 |
BR0010909A (pt) | 2002-02-19 |
CN1191861C (zh) | 2005-03-09 |
NZ515598A (en) | 2004-05-28 |
PL352159A1 (en) | 2003-07-28 |
EP1180369A4 (en) | 2002-07-24 |
HUP0201333A3 (en) | 2004-11-29 |
EP1180369A1 (en) | 2002-02-20 |
AU4948600A (en) | 2000-12-12 |
TR200103396T2 (tr) | 2002-04-22 |
HUP0201333A2 (en) | 2002-08-28 |
US6746673B2 (en) | 2004-06-08 |
RU2222347C2 (ru) | 2004-01-27 |
WO2000071160A1 (fr) | 2000-11-30 |
AU761544B2 (en) | 2003-06-05 |
NO20015711D0 (no) | 2001-11-23 |
CZ20014181A3 (cs) | 2002-03-13 |
AU761544C (en) | 2004-02-12 |
US20020103212A1 (en) | 2002-08-01 |
CN1364090A (zh) | 2002-08-14 |
NO20015711L (no) | 2002-01-11 |
MXPA01012206A (es) | 2002-06-21 |
CA2373992A1 (en) | 2000-11-30 |
KR20020008197A (ko) | 2002-01-29 |
HK1042049A1 (zh) | 2002-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL146566A0 (en) | A pharmaceutical composition containing anti-fas antibody | |
IL145177A0 (en) | A pharmaceutical composition containing xenon | |
IL187526A0 (en) | Pharmaceutical compositions containing an a?? fragment | |
PL351387A1 (en) | Pharmaceutical composition | |
HUP0400644A3 (en) | Pharmaceutical compositions containing aspirin | |
IL146632A0 (en) | Pharmaceutical tablets | |
HUP0000137A3 (en) | Controller-release pharmaceutical composition containing anangetics | |
IL145632A0 (en) | Pharmaceutical compounds | |
GB0031084D0 (en) | Pharmaceutical compounds | |
EG23937A (en) | Novel pharmaceutical | |
GB9916434D0 (en) | Pharmaceutical compounds | |
GB9914255D0 (en) | Pharmaceutical compounds | |
GB9909041D0 (en) | Novel pharmaceutical | |
GB9903784D0 (en) | Pharmaceutical compounds | |
EG23946A (en) | Novel pharmaceutical | |
GB0019272D0 (en) | Pharmaceutical compounds | |
GB2373499B (en) | Pharmaceutical compounds | |
GB0024318D0 (en) | Pharmaceutical compounds | |
GB0005366D0 (en) | Pharmaceutical compounds | |
GB9923933D0 (en) | Novel pharmaceutical | |
HU9900064V0 (en) | Dispenser for pills | |
SI1169298T1 (sl) | Framacevtske spojine | |
SI1252133T1 (en) | Pharmaceutical compounds | |
GB0031579D0 (en) | Pharmaceutical compounds | |
GB0012534D0 (en) | Pharmaceutical compounds |